Last deal

Amount

Series A

Stage

31.10.2022

Date

2

all rounds

$13.6M

Total amount

General

About Company
PlusLife Biotech creates molecular diagnostic tools using new genetic technologies.

Industry

Sector :

Subsector :

Also Known As

Pluslife Biotech, Guangzhou Pluslife Biotech Co., Ltd

founded date

01.07.2017

Last funding type

Series A

IPO status

Private

Description

The Guangzhou-based company, founded in 2017, is focused on developing innovative molecular diagnostic tools and gene treatment programs utilizing the latest gene technology. PlusLife Biotech has developed a range of molecular POCT detection card products and detection reagent products for various applications, including respiratory and reproductive tract infections, genotype detection, and pet disease detection. These products offer customers affordable and user-friendly testing options.